Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed)
Key Information
Due Date: August 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
We recognize that there have been tremendous advancements in recent years regarding identifying novel targets, mechanisms and paths of interest relevant to substance use disorders. This includes recognizing probes and optimizing compounds for creating new therapeutic agents. We want this program to empower investigators who possess knowledge in the rapidly evolving chemical, pharmacological and drug discovery technologies to conduct innovative and groundbreaking research on the chemical and pharmacological elements of substance use disorders.
Please note clinical trials are not permitted under this Award Program.
Key Dates
Open Date: October 20, 2022
Application Due Date: August 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses